The Philippines Food and Drug Administration (FDA) has issued FDA Circular No. 2022-004, which provides insight on the facilitated registration pathways (FRPs) available for new drugs (including vaccines and biologicals),
read more...Regulatory News
Hong Kong Drug Office Releases Guidance Notes on Classification of Products
Hong Kong Drug Office has published some guidance notes on the classification of products as “pharmaceutical products” in June 2022.
A product will need to be assessed to determine its eligibility
Thailand FDA and Singapore HSA Collaborate on Expedited Medical Device Registration Program
The Food and Drug Administration (FDA) of Thailand and Health Sciences Authority (HSA) Singapore have formed an expedited program to support the registration of medical devices in Thailand. The latest
read more...MDA Malaysia Releases Latest Guidance on Classification for General Medical Devices
The Malaysian Medical Device Authority (MDA) has released the second edition of the guidance document on the rules of classification for general medical devices in May 2022.
There are updates to
read more...Australia TGA Issues Factsheet on Software-Based Medical Devices in Digital Mental Health
The Therapeutic Goods Administration (TGA) Australia has released a factsheet on software based medical devices in digital mental health in May 2022.
Some examples of these medical devices include any app
Hong Kong Drug Office Updates Frequently Asked Questions’ Page
Hong Kong Drug Office has provided the latest set of frequently asked questions (FAQs) on their official website at the end of April 2022.
The page for FAQs covers a range
Singapore HSA Publishes Updated Guidelines on Software Medical Devices
The Health Sciences Authority (HSA) Singapore has published an updated version of the guidelines for software medical devices (MD) in April 2022.
One of the updates is under the pre-market product
Philippines FDA Updates Circular on Transition Period for Certificate of Medical Device Notification
The Philippines Food and Drug Administration (FDA) has issued FDA Circular No. 2021-002-B, an amended version of Circular No. 2021-002-A. This is an addendum to Circular No. 2021-002, which contains
read more...Singapore HSA Publishes Guidelines on Risk Classification of Standalone Medical Mobile Applications and Qualification of Clinical Decision Support Software
The Health Sciences Authority (HSA) Singapore has published the first version of the guidelines on the determination of risk classification of standalone medical mobile applications that are medical devices, which
read more...